Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Axoft Starts Commercializing Soft BCI-Enabling Materials For R&D Use, Aims To Rewrite BCI Playbook

May 14 2025

• By Marion Webb

Axoft implant, next to a quarter for scale — (Axoft)

Related Content

Subsense Develops Nonsurgical, Nanoparticle-Based Brain-Computer Interface For Neurological Disorders

May 05 2025

Precision Neuroscience’s FDA Clearance For Core Component Of Brain Implant Expected to Accelerate R&D

Apr 18 2025

Axoft’s CEO Sees Potential For Soft Neural Implant To Help Coma Patients With Signs Of Brain Activity Communicate

Jan 22 2025

Inbrain Has Sights On Parkinson’s Following First-In-Human Test Of Graphene-Based Implant

Oct 03 2024

Synchron Announces Positive Results From Stentrode BCI Study, Plans For Pivotal Study

Oct 01 2024

Additional Topics

Mental health Neurology Academics Research & Development FDA Clinical Clinical Trials Comp

More from Clinical Trials

More from Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window